Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ploug

Showing results (61-70 of 127) with videos related to

Pageof 13
Sort By:
FEBS Letters|May 3, 2019
Crystal structure of the unoccupied murine urokinase-type plasminogen activator receptor (uPAR) reveals a tightly packed DII-DIII unitMin Liu, Lin Lin, Gunilla Høyer-Hansen, et al.
Journal of the American Society of Nephrology : JASN|May 3, 2014
Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in miceDominique Cathelin, Sandrine Placier, Michael Ploug, et al.
Plos One|September 22, 2010
Neutralisation of uPA with a monoclonal antibody reduces plasmin formation and delays skin wound healing in tPA-deficient miceAnnika Jögi, Birgitte Rønø, Ida K Lund, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2012
Quantitative PET of human urokinase-type plasminogen activator receptor with 64Cu-DOTA-AE105: implications for visualizing cancer invasionMorten Persson, Jacob Madsen, Søren Østergaard, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 3, 2016
Tissue Inhibitor of Metalloproteinase-1 Is Confined to Tumor-Associated Myofibroblasts and Is Increased With Progression in Gastric AdenocarcinomaWarner Alpízar-Alpízar, Ole Didrik Laerum, Ib J Christensen, et al.
International Journal of Molecular Sciences|June 15, 2019
Evolution and Medical Significance of LU Domain-Containing ProteinsJulie Maja Leth, Katrine Zinck Leth-Espensen, Kristian Kølby Kristensen, et al.
Data in Brief|October 28, 2015
Mapping the topographic epitope landscape on the urokinase plasminogen activator receptor (uPAR) by surface plasmon resonance and X-ray crystallographyBaoyu Zhao, Sonu Gandhi, Cai Yuan, et al.
Circulation Research|November 13, 2014
GPIHBP1 missense mutations often cause multimerization of GPIHBP1 and thereby prevent lipoprotein lipase bindingAnne P Beigneux, Loren G Fong, André Bensadoun, et al.
Frontiers in Cell and Developmental Biology|August 2, 2021
GPIHBP1 and ANGPTL4 Utilize Protein Disorder to Orchestrate Order in Plasma Triglyceride Metabolism and Regulate Compartmentalization of LPL ActivityKristian Kølby Kristensen, Katrine Zinck Leth-Espensen, Anni Kumari, et al.
BMC Evolutionary Biology|January 19, 2019
Origin and diversification of the plasminogen activation system among chordatesAndrés Chana-Muñoz, Agnieszka Jendroszek, Malene Sønnichsen, et al.
Pageof 13

Showing results (61-70 of 127) with videos related to

Sort By:
Pageof 13
FEBS Letters|May 3, 2019
Crystal structure of the unoccupied murine urokinase-type plasminogen activator receptor (uPAR) reveals a tightly packed DII-DIII unitMin Liu, Lin Lin, Gunilla Høyer-Hansen, et al.
Journal of the American Society of Nephrology : JASN|May 3, 2014
Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in miceDominique Cathelin, Sandrine Placier, Michael Ploug, et al.
Plos One|September 22, 2010
Neutralisation of uPA with a monoclonal antibody reduces plasmin formation and delays skin wound healing in tPA-deficient miceAnnika Jögi, Birgitte Rønø, Ida K Lund, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2012
Quantitative PET of human urokinase-type plasminogen activator receptor with 64Cu-DOTA-AE105: implications for visualizing cancer invasionMorten Persson, Jacob Madsen, Søren Østergaard, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 3, 2016
Tissue Inhibitor of Metalloproteinase-1 Is Confined to Tumor-Associated Myofibroblasts and Is Increased With Progression in Gastric AdenocarcinomaWarner Alpízar-Alpízar, Ole Didrik Laerum, Ib J Christensen, et al.
International Journal of Molecular Sciences|June 15, 2019
Evolution and Medical Significance of LU Domain-Containing ProteinsJulie Maja Leth, Katrine Zinck Leth-Espensen, Kristian Kølby Kristensen, et al.
Data in Brief|October 28, 2015
Mapping the topographic epitope landscape on the urokinase plasminogen activator receptor (uPAR) by surface plasmon resonance and X-ray crystallographyBaoyu Zhao, Sonu Gandhi, Cai Yuan, et al.
Circulation Research|November 13, 2014
GPIHBP1 missense mutations often cause multimerization of GPIHBP1 and thereby prevent lipoprotein lipase bindingAnne P Beigneux, Loren G Fong, André Bensadoun, et al.
Frontiers in Cell and Developmental Biology|August 2, 2021
GPIHBP1 and ANGPTL4 Utilize Protein Disorder to Orchestrate Order in Plasma Triglyceride Metabolism and Regulate Compartmentalization of LPL ActivityKristian Kølby Kristensen, Katrine Zinck Leth-Espensen, Anni Kumari, et al.
BMC Evolutionary Biology|January 19, 2019
Origin and diversification of the plasminogen activation system among chordatesAndrés Chana-Muñoz, Agnieszka Jendroszek, Malene Sønnichsen, et al.
Pageof 13